MANGOCEUTICALS, INC.
For the period ended Dec 31, 2025. Filed Apr 1, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 1, 2026
MGRX$0.19-4.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| For The Year Ended · For The Year Ended | ||||
|---|---|---|---|---|
| December 31, 2025 · December 31, 2024 | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net loss | $(20,643,455) | $(8,707,226) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation | 1,012 | 9,936 | ||
| Issuance of common stock for services | 10,716,692 | 2,106,265 | ||
| Options vested for stock-based compensation | 1,168,280 | 248,682 | ||
| Loss on sale of assets | - | 18,387 | ||
| Amortization of intangible assets | 1,122,639 | 721,533 | ||
| Amortization of license agreement | 600,552 | - | ||
| Operating lease right of use asset | 68,539 | 59,769 | ||
| Inventory obsolescence | - | 18,501 | ||
| Loss from settlement | 125,624 | - | ||
| Loss from debt extinguishment – related parties | 19,388 | - | ||
| (Increase) decrease in operating assets: | ||||
| Due from related party | (20,056) | - | ||
| Impairment of license agreement | 1,239,942 | - | ||
| Prepaid expenses - related party | (120) | 60,953 | ||
| Prepaid expenses | (7,021) | - | ||
| Deposits | (16,957) | - | ||
| (Decrease) increase in operating liabilities: | ||||
| Accounts payable and accrued liabilities | 55,669 | 696,736 | ||
| Accrued liabilities - related parties | - | (63,717) | ||
| Operating lease right-of-use liabilities | (74,046) | (6,595) | ||
| Payroll tax liabilities | 9,421 | - | ||
| Other liabilities | (216,358) | (27,000.00) | ||
| NET CASH USED IN OPERATING ACTIVITIES | (5,850,255) | (4,863,776) | ||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Sale of assets | - | 65,000 | ||
| NET CASH PROVIDED BY(USED IN) INVESTING ACTIVITIES | - | 65,000 | ||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Proceeds from borrowings on notes payable | 500,000 | 150,000 | ||
| Proceeds from borrowings on notes payable - related parties | 175,000 | - | ||
| Proceeds from sales of common stock | 4,625,355 | 1,328,268 | ||
| Proceeds from sales of series B convertible preferred stock | 100,000 | 2,650,000 | ||
| Proceeds from exercise of warrants | 927,000 | - | ||
| Collection of subscriptions receivable | 1,150,000 | - | ||
| Repayment of borrowings on notes payable - related parties | (206,500) | - | ||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 7,270,855 | 4,128,268 | ||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ||||
| End of period | 1,420,600 | (670,508) | ||
| CASH AND CASH EQUIVALENTS: | ||||
| Beginning of period | 58,653 | 739,006 | ||
| Effects of currency translation on cash and cash equivalents | 7,085 | (9,845) | ||
| End of period | $1,486,338 | $58,653 | ||
| Supplemental disclosure of cash flow information: | ||||
| Cash paid for income taxes | $ | - | $ | - |
| Cash paid for interest | $ | - | $ | - |
| $ | - | $ | - | |
| Supplemental schedule of non-cash investing and financing activities: | ||||
| Right of use assets acquired under new operating leases | $316,907 | $ | - | |
| Issuance of common stock for license agreement | $1,963,000 | $ | - | |
| Issuance of common stock for patent acquisition | $ | - | $1,344,150 | |
| Issuance of Series C Convertible Preferred for patent acquisition | $ | - | $14,210,000 | |
| Issuance of common stock for payment of Preferred B dividend | $ | - | $70,168 | |
| Issuance of common stock for settlement of debt settlement | $590,000 | $ | - | |
| Issuance of common stock for settlement of note payable | $500,000 | $ | - | |
| Issuance of common stock for settlement of note payable - related parties | $150,000 | $ | - | |
| Issuance of common stock for conversion of Series B Convertible Preferred | $201 | $1,133,000 | ||
| Issuance of common stock for cashless warrant exercise | $23 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.